Mission Statement, Vision, & Core Values of Ginkgo Bioworks Holdings, Inc. (DNA)

In a world increasingly shaped by technological advancements, how is biology being engineered to solve pressing global challenges? Ginkgo Bioworks, a leader in synthetic biology, strives to 'make biology easier to engineer,' but what does this mission mean in practice, and how does it translate into tangible results?

With a vision to revolutionize how we think about biological engineering, Ginkgo Bioworks aims to be at the forefront of innovation, leveraging custom microbes and biological products to tackle issues ranging from sustainable agriculture to renewable energy. But what are the core values that guide this innovative approach, and how did the company perform financially in its mission to make biology easier to engineer, reporting a total revenue of $227 million for the full year 2024?

Ginkgo Bioworks Holdings, Inc. (DNA) An Overview of

Ginkgo Bioworks is a biotechnology company focused on engineering biology to create new products in various industries. As of April 2025, Ginkgo Bioworks continues to serve industries such as:

• Pharmaceuticals
• Agriculture
• Food
• Cosmetics

By leveraging its platform for cell programming, Ginkgo designs and produces biological products, offering its services to businesses looking to innovate through synthetic biology.

In the latest financial reports, Ginkgo Bioworks has demonstrated substantial financial performance. For the fiscal year 2024, the company reported record-breaking revenue, driven significantly by its core platform services. A notable portion of this revenue came from key partnerships and collaborations across various sectors. The company's strategic focus on expanding its platform capabilities and market reach has led to significant growth, positioning it as a key player in the synthetic biology field. More detailed insights into Ginkgo Bioworks' financial health can be found at: Breaking Down Ginkgo Bioworks Holdings, Inc. (DNA) Financial Health: Key Insights for Investors

Ginkgo Bioworks has established itself as a leader in the synthetic biology industry through its innovative approach to cell programming and its wide-ranging applications across multiple sectors. Its success is rooted in its ability to engineer biology to solve complex problems and create valuable products. To understand more about the reasons behind Ginkgo Bioworks' success, explore further details about its strategic vision and operational execution.

Ginkgo Bioworks Holdings, Inc. (DNA) Mission Statement

Ginkgo Bioworks' mission is to make biology easier to engineer. This mission drives the company's strategic goals and aspirations, shaping its approach to synthetic biology and its role across various industries.

Analyzing Ginkgo Bioworks' mission statement reveals three core components:

• Focus on Biology: Ginkgo Bioworks centers its efforts on biology, specifically leveraging biological systems and processes to create innovative solutions.
• Engineering Emphasis: The company emphasizes engineering principles to design and construct biological systems, ensuring they are predictable and reliable.
• Simplification Goal: A key objective is to simplify the complexities of biology, making it more accessible and manageable for various applications.

These components collectively highlight Ginkgo Bioworks' commitment to advancing synthetic biology, offering new tools and capabilities across diverse sectors. Ginkgo Bioworks aims to drive innovation and create value by making biology easier to engineer. For more insights into Ginkgo Bioworks' financial standing, see: Breaking Down Ginkgo Bioworks Holdings, Inc. (DNA) Financial Health: Key Insights for Investors

Ginkgo Bioworks Holdings, Inc. (DNA) Vision Statement of

Ginkgo Bioworks' vision is to make biology easier to engineer. This overarching goal permeates their strategic initiatives and daily operations, influencing how they approach synthetic biology and its applications across diverse industries.

Engineering Biology for Broad Applications

Ginkgo Bioworks aims to make engineered biology accessible and valuable across a wide array of sectors. This involves:

• Developing a robust platform for programming cells that can be applied to create products in fields ranging from pharmaceuticals to agriculture.
• Focusing on innovations that enable the cost-effective and scalable production of biological products.

In fiscal year 2024, Ginkgo Bioworks reported several key achievements that underscore this vision. For example, the company expanded its cell programming platform, increasing the number of available biological 'parts' to over 100 million, enhancing its ability to design and produce novel biological solutions. Furthermore, strategic partnerships in the agricultural sector led to the development of more sustainable and efficient methods for crop enhancement, reflecting the practical application of their engineered biology.

Democratizing Access to Biological Engineering

A core component of Ginkgo’s vision involves democratizing access to biological engineering. This entails:

• Lowering the barriers to entry for companies and researchers looking to leverage synthetic biology.
• Providing tools, resources, and expertise that enable a broader audience to innovate using biological systems.

As of 2024, Ginkgo has significantly reduced the cost of DNA synthesis and other critical processes, making it more feasible for smaller companies and academic institutions to engage in advanced biological research. The company’s partnerships with universities and research institutions have further facilitated the dissemination of knowledge and technology, fostering a collaborative ecosystem. For instance, Ginkgo's support for synthetic biology research programs at multiple universities has resulted in a 30% increase in student participation in related fields.

Pioneering New Biological Products and Markets

Ginkgo Bioworks envisions itself as a pioneer in creating entirely new categories of biological products and opening up new markets. This includes:

• Investing in research and development to explore the potential of synthetic biology in addressing unmet needs.
• Collaborating with industry partners to bring innovative biological solutions to market.

In 2024, Ginkgo expanded its work in developing novel enzymes for industrial processes, leading to more efficient and environmentally friendly manufacturing techniques. The company’s forays into biomanufacturing new materials have also shown promise, with early-stage projects demonstrating the potential to replace traditional, less sustainable materials with biologically derived alternatives. Revenue from new market segments constituted approximately 15% of Ginkgo’s total revenue in 2024, indicating successful diversification and market penetration.

Advancing Sustainability and Global Well-being

Ginkgo Bioworks integrates a commitment to sustainability and global well-being into its vision. This involves:

• Developing biological solutions that can help address pressing environmental challenges, such as climate change and pollution.
• Promoting the responsible and ethical use of synthetic biology to benefit society.

Ginkgo’s work in developing microbes that can capture and convert greenhouse gases has gained traction, with pilot projects showing a 20% improvement in carbon capture efficiency compared to previous methods. Additionally, their efforts to engineer microbes for bioremediation have led to more effective and sustainable ways to clean up contaminated sites. In 2024, Ginkgo allocated 25% of its R&D budget to projects focused on environmental sustainability, underscoring its commitment to addressing global challenges through biological innovation.

More insights about the company can be found here: Ginkgo Bioworks Holdings, Inc. (DNA): History, Ownership, Mission, How It Works & Makes Money

Ginkgo Bioworks Holdings, Inc. (DNA) Core Values of

While specific, officially documented core values of Ginkgo Bioworks are not publicly available as of April 2025, we can analyze their mission, vision, and activities to infer the values that drive the company. Based on available information, likely core values include innovation, customer centricity, sustainability, and collaboration. To learn more about Ginkgo Bioworks, you can visit: Ginkgo Bioworks Holdings, Inc. (DNA): History, Ownership, Mission, How It Works & Makes Money

Innovation: Ginkgo Bioworks operates at the cutting edge of synthetic biology, constantly seeking new ways to engineer organisms for a variety of applications. This commitment to innovation is evident in their continuous development of new technologies and platforms. For example, in 2024, Ginkgo expanded its capabilities in mRNA manufacturing and drug discovery through key acquisitions and partnerships. These moves enhance their ability to innovate in biopharmaceutical applications, reflecting a dedication to pushing the boundaries of what's possible in synthetic biology.

Customer Centricity: Ginkgo's business model revolves around providing its platform and services to a diverse range of customers, from agriculture to pharmaceuticals. Their focus on meeting customer needs is demonstrated by their strategic partnerships and collaborations aimed at solving specific industry challenges. In 2024, Ginkgo announced multiple new and expanded partnerships, highlighting their commitment to tailoring their offerings to meet the unique demands of their clients. This customer-focused approach is crucial for driving adoption of their platform and expanding their market reach.

Sustainability: As a company focused on engineering biology, Ginkgo Bioworks has the potential to contribute significantly to sustainable solutions across various industries. This commitment is reflected in their work on developing more sustainable agricultural practices, alternative materials, and biomanufacturing processes. Ginkgo's partnership with Bayer, announced in 2022 and ongoing through 2024, to engineer microbes for more sustainable nitrogen fertilizer use in agriculture exemplifies this value. Such initiatives align with global efforts to reduce environmental impact and promote sustainable practices.

Collaboration: Given the complexity of synthetic biology and the wide range of applications Ginkgo serves, collaboration is likely a core value. They actively engage with partners across different sectors to leverage their expertise and resources. Ginkgo's numerous partnerships, including those with Novo Nordisk and Alphabet’s Verily, illustrate their collaborative approach. These collaborations enable Ginkgo to access new markets, technologies, and expertise, accelerating innovation and expanding the impact of their platform.